ABSTRACT
INTRODUCTION
Ovarian cancer is the seventh most common cancer diagnosed among women worldwide, and the fifth most common cancer diagnosed among women in more developed regions, especially in Europe 1 . High-grade serous carcinomas are the most common type of ovarian carcinoma, usually manifesting as advanced-stage disease (approximately 80% of cases) 2 . Complete resection to no residual disease at primary 3 -6 or interval 7 debulking surgery has been shown to be the single most important independent prognostic factor in advanced ovarian cancer. Primary surgery should be the preferred treatment strategy, while neoadjuvant chemotherapy should be limited to selected patients with tumor dissemination implying no chance for complete resection or to patients with contraindications to upfront debulking surgery 8 . The clinical decision regarding primary debulking depends on many factors such as patient characteristics, institutional infrastructure and surgical skills and experience 9 , and on the probability of achieving no residual tumor. The important information on tumor resectability is provided by preoperative imaging, although the best way to ascertain whether complete debulking can be achieved is by surgical examination 10, 11 . Computed tomography (CT) is the imaging modality used most commonly for preoperative staging and follow-up of ovarian cancer 12, 13 . Conventional magnetic resonance imaging (MRI) has certain advantages over CT, such as higher soft-tissue contrast and no radiation exposure for the patients. Conventional MRI currently plays a problem-solving role, particularly if there is suspicion of pelvic side-wall invasion, and it can be used in situations in which CT is contraindicated 12, 13 . The addition of diffusion-weighted imaging (DWI) to morphological imaging (conventional MRI) improves tumor characterization and peritoneal and lymph node staging 14 -17 . The main limitations for the use of MRI as a first-line technique are the long examination time, susceptibility to patient motion and bowel peristalsis, high cost and limited availability. The role of another promising modern imaging modality, positron emission tomography with CT (PET/CT), over CT alone in preoperative staging of ovarian cancer has not yet been fully established. Until recently, ultrasound imaging has been used sparsely in the preoperative staging of ovarian cancer. However, its use is increasing, following the development of high-resolution endovaginal probes, which allow detailed visualization of the pelvic anatomy, comparable to that of MRI 18 . Transabdominal scans additionally provide detailed information on the status of parenchymatous organs, lymph nodes and peritoneum in the abdomen 19 . Ultrasound has the further advantages of being cheap and commonly available, and not posing risk or causing discomfort to the patient. There are only two published studies focusing on the role of ultrasound in preoperative staging of ovarian cancer 20, 21 .
The present study aimed to evaluate prospectively the diagnostic performance of ultrasound in consecutive patients undergoing treatment for ovarian cancer at a gynecological oncology center, in order to analyze its accuracy and limitations in preoperative assessment of pelvic and intra-abdominal spread.
METHODS
This prospective diagnostic accuracy study followed the STARD statement for the reporting of diagnostic accuracy studies, published in January 2003 and updated in 2015 (www.stard-statement.org) 22, 23 . It evaluated the diagnostic performance of transvaginal and transabdominal two-dimensional ultrasound in the preoperative staging of ovarian cancer.
Participants
The study was initiated in a gynecological oncology center and run in the period between March 2008 and January 2013. We enrolled consecutive patients referred for primary cytoreductive surgery for suspected ovarian cancer. Eligible participants were selected by subjective assessment of the ovarian mass during an initial ultrasound examination by one of three examiners (D.F., M.Z., I.S.). If the ultrasound expert suspected primary ovarian cancer, the index test (ultrasound assessment of tumor spread using study evaluation form) was carried out during the same ultrasound examination. One of three highly experienced oncosurgeons (D.C., J.S. and M.Z.) selected patients suitable for upfront surgery, which was performed within 4 weeks after the index test, and the surgeon filled out the study evaluation form regarding the extent of peritoneal spread according to intraoperative findings. The study evaluation form was created in advance by a consensus of ultrasound experts, oncosurgeons and pathologists participating in the study (Table S1 ). The reference standard was intraoperative findings in combination with the histological report.
The ultrasound scan always consisted of tumor-specific diagnosis as well as a systematic evaluation of tumor spread in the pelvis and abdomen, including a description of tumor distribution in locations not suitable for primary cytoreduction (e.g. non-resectable liver parenchymal metastases; tumor involving duodenum and/or large parts of pancreas; tumor infiltrating large vessels of celiac trunk and hepatoduodenal ligamentum, and metastases behind the porta hepatis; tumoral infiltration of the superior mesenteric artery and mesenterial root of the small bowel; diffuse and confluent carcinomatosis of the stomach and/or small bowel). This systematic ultrasound examination was the basis for the clinical decision regarding immediate tumor resectability; the possibility of using ultrasound to triage patients to upfront surgery or neoadjuvant chemotherapy has been demonstrated in a previous study from our center 24 . With the exception of X-ray or CT of the lung, which were used routinely to assess supradiaphragmatic spread, other imaging techniques were used only selectively.
The main criteria precluding upfront debulking surgery were medical comorbidities preventing major surgery and disease-related factors 8, 10 . In our study, any contraindication to surgery was based on the clinical decision of the experienced oncosurgeons and followed the institutional guidelines. If neoadjuvant chemotherapy was initiated, the enrolled patient was retained in the study and the index test was repeated before interval debulking surgery (after three courses of neoadjuvant chemotherapy).
Exclusion criteria were: subjective assessment of ovarian tumor not consistent with primary ovarian cancer, debulking surgery later than 4 weeks after ultrasound, contraindication to surgery, absence of index test (incomplete ultrasound evaluation form), absence of reference standard (incomplete intraoperative evaluation form and/or missing corresponding pathological report from surgical resection), final histology of benign, borderline or secondary ovarian tumor.
The local ethics committee approved the study protocol and informed written consent was obtained from all subjects.
Test method (index test)
Each examination was performed by one of three examiners (D.F., M.Z., I.S.) experienced in transvaginal and transabdominal ultrasound (>15, > 10 and > 5 years' experience, respectively). The ultrasound scan was performed with a Voluson E8 (GE Medical Systems, Zipf, Austria) ultrasound machine, equipped with a 5-9-MHz RIC5-9 transducer, 3.5-7-MHz matrix convex transducer and 4-13-MHz linear array transducer. No preparation of patients, such as enema or fasting, was necessary. During ultrasound no contrast agent was used, therefore ultrasound examination provided no risk to patients and had no contraindications. The digital videoclips obtained during real-time observation while assessing all anatomical areas were stored.
Image interpretation and analysis
For the purpose of this study, we focused on the diagnosis of tumor spread in the peritoneum and inguinal and retroperitoneal lymph nodes. Peritoneal involvement was classified, according to the type of peritoneum affected by cancer cell dissemination, into parietal, visceral, mesenterial and omental carcinomatosis ( Figure 1 ).
The lymph nodes were classified as peripheral, such as inguinal (Figure 2d ), or non-peripheral. The latter were subdivided into retroperitoneal ( Figure 2d ) and visceral (Figure 2e ) nodes. The retroperitoneal lymph nodes were classified into iliac (pelvic) and paraaortic (abdominal). The abdominal visceral lymph nodes were classified into celiac (around hepatic and splenic hilum) and mesenteric (around superior and inferior mesenteric artery); for the purposes of this study, they were not evaluated separately from peritoneal implants infiltrating the hepatic or splenic hilum or mesentery because it is almost impossible to discriminate peritoneal nodules from infiltrated visceral lymph nodes using imaging.
A detailed review on how to scan ovarian cancer for staging (methodology, terminology, clinical implementation) has been published previously 19 . Terms, definitions and measurements to describe peritoneal and lymph node spread are given in Figure 3 . The ultrasound examiner evaluated the presence of peritoneal and lymphatic spread on the basis of morphological findings. Doppler was used additionally in the assessment of lymph node perfusion in patients for whom gray-scale sonographic features were equivocal. Specifically, the observation of vessel location and distribution of intranodal vascularity was useful in differentiating malignant from benign lymphadenopathy ( Figure 3) .
The routine transvaginal ultrasound examination for patients with suspected ovarian cancer commenced with a subjective assessment of the adnexal mass with description of tumor(s) using International Ovarian Tumor Analysis (IOTA) terminology 25 . If there was suspicion of primary ovarian cancer, the standardized ultrasound study evaluation form was followed (Table S1, Figure 2a -e and Videoclips S1-S4, with commentary in Appendix S1). Infiltration of pelvic peritoneum as well as density and size of carcinomatosis were assessed. If the posterior compartment was infiltrated, the presence and depth of rectosigmoid wall infiltration were evaluated ( Figure 2a and Videoclip S1). The transvaginal examination also allowed detailed evaluation of the lateral side walls, including detection of infiltrated iliac lymph nodes ( Figure 2d and Videoclip S4).
A transabdominal scan was then performed as follows. First, the upper abdomen was examined from left to right hypochondrium (diaphragm, spleen, liver, lesser omentum) (Figure 2b and Videoclip S2). Then, the middle abdomen was assessed ( Figure 2c and Videoclip S3), including evaluation of the anterior abdominal wall, the greater omentum in relation to the transverse colon, and the right lateral space (ileocecum, mesoappendix, ascending colon, paracolic fossa) from ileocecum to right colonic flexure. The surface of the transverse colon and transverse mesocolon from right to left colonic flexure was observed as was the left lateral space, from left colonic flexure to sigmoid colon crossing the left iliac vessels and entering the pelvis. In the left lateral space we assessed the descending and sigmoid colon, sigmoid mesocolon and left paracolic fossa. The overall evaluation of the small bowel started in the epigastric region by imaging the duodenal bulb through the duodenal descendant and horizontal parts up to the left epigastric-subcostal region (D4). The jejunum and non-terminal ileum, due to their length and variable location and the lack of patient fasting and preparation (oral contrast agent), were screened grossly for visceral carcinomatosis up to the terminal ileum in the right lower quadrant. The mesentery of the intestine was examined systematically while examining the lymph nodes (see below) ( Figure 2e ). Lastly, the probe was moved from the left lateral space to the left groin in order to examine the inguinal lymph nodes following the femoral vessels, the left iliac lymph nodes around external, internal and common iliac vessels, and the lymph nodes around the aorta and inferior vena cava up to the diaphragm ( Figure 2d and Videoclip S4). We discriminated between paraaortic (to right of aorta), preaortic (anterior to aorta), retroaortic (dorsal to aorta), interaortocaval (between aorta and inferior vena cava) and pre-, retro-and paracaval lymph nodes. By following the superior and inferior mesenteric arteries, which descend anteriorly to the aorta then pass to its left as they continue inferiorly, the visceral lymph nodes and left-sided mesentery were evaluated ( Figure 2e ). The same procedure was carried out on the right side, starting at the right groin for assessment of the right inguinal lymph nodes, followed by examination around the right iliac vessels, aorta and inferior vena cava to the diaphragm, in order to detect retroperitoneal lymph nodes ( Figure 2d and Videoclip S4). By following the superior and inferior mesenteric veins, which are located closer to the inferior vena cava, running anterior and to the right of it, the right mesentery was examined in order to detect visceral lymph nodes and mesenterial carcinomatosis (Figure 2e ). The evaluation of hematogenous parenchymatous metastases was a standard part of the ultrasound examination ( Figure 2f ), but was not included in the study evaluation form (Table S1 ) due to lack of the standard reference in the majority of patients with hematogenous parenchymatous metastases.
When completing the ultrasound study evaluation form, the sonographer described the amount of free fluid (only in pelvis, small volume of ascites (only around liver and/or spleen) or large volume of ascites (throughout abdomen)) and assigned the FIGO stage of tumor spread. Because this prospective study commenced in 2008, the old FIGO classification rules 26 , published in 2000, were used rather than the new FIGO staging, published in 2014 27 . 
Outcome
To meet the inclusion criteria, cases required, in addition to a complete ultrasound evaluation, an intraoperative evaluation report and histological diagnosis from surgical resection. The decision regarding surgery was made by the experienced oncosurgeons, based on the evaluation of clinical data and imaging. The procedure was always initiated as open surgery. Primary tumors and peritoneal spread were confirmed intraoperatively initially, backed up with histopathology. The size distribution of metastatic lesions was recorded at surgical evaluation by measuring the largest isolated lesion or the largest width of diffuse carcinomatosis per region. The depth of rectosigmoid infiltration and retroperitoneal metastatic spread were confirmed primarily by histopathology after surgery. Resection specimens were labeled before fixation, and histopathological findings were reported. When surgical and pathological findings were discordant, pathological findings prevailed.
Statistical analysis
Absolute and relative frequencies were used to describe true and false positive and negative combinations of preoperative ultrasound and intraoperative findings. Receiver-operating characteristics (ROC) curve analysis was applied to assess the predictive power of ultrasound, taking subsequent intraoperative findings complemented with the pathological report as a reference endpoint (area under the ROC curve (AUC) and its statistical significance), supplemented by standard diagnostic measures of the predictive power of ultrasound (specificity, sensitivity, positive predictive value, negative predictive value, overall accuracy). Analysis was carried out using SPSS 23.0.0.0 (IBM SPSS Statistics, IBM Corp., Armonk, NY, USA).
RESULTS

Participants
The STARD flow diagram summarizing recruitment and inclusion in this prospective study is given in Figure 4 . Enrolled into the study were 578 consecutive patients with an ovarian mass suspected to be ovarian cancer who were referred to the gynecological oncology center for treatment between March 2008 and January 2013. Exclusions from the study included patients with absence of a primary ovarian malignant tumor suspected of being cancer on ultrasound (n = 30), those contraindicated to surgery (n = 21), patients with absence of the index test (n = 2) or absence of the reference standard (borderline ovarian tumor, n = 89, metastatic ovarian tumor, n = 27, and those with intraoperative findings indicating them to
Size of Carcinomatosis
Isolated Isolated implants without tendency to merge together.
Diffuse
Nodules in close proximity with tendency to merge together and form sheet-like appearance.
In cases of isolated nodule largest diameter was measured, while in cases of sheet-like carcinomatosis its widest diameter was measured perpendicular to surface of underlying structure (e.g. abdominal wall, viscera, bowel).
Isolated nodules within omentum.
Confluent nodules forming diffuse infiltration, also called omental cake.
Bean-shaped with an echogenic medulla, peripheral hypoechogenic lymphoid tissue, echogenic capsule and pronounced hyperechogenic hilum. A strip of vessels (hilar longitudinal vessels) may be visualized. Normal nodes tend to have only hilar vascularity or appear avascular.
Oval nodes due to enlargement of reactive centers in the paracortex with symmetrical parenchymal widening. There is pronounced hilar perfusion with radial branching from the hilum. Rarely, reactive lymph nodes may also have no visible hilum sign and display a hypoechogenic center, rounded shape or irregular margins.
During healing process of reactive lymph nodes the echogenic center becomes larger, with lipomatous changes in the sinuses of the medulla. These changes, together with the presence of only longitudinal hilar vessels, are indicative of postreactive lymph nodes.
Due to tumor-cell load the lymph nodes become round, with loss of the hilum sign and inhomogeneous due to calcifications, necrosis or partial infiltration. Partial infiltration appears as asymmetrical parenchymal widening (1) called focal cortical hyperplasia or eccentric cortical hypertrophy. If partial infiltration is found, malignant node may still exhibit hilar hyperechogenicity. Irregular or blurred margins usually indicate extracapsular and extranodal spread. Similary, intranodal necrosis indicates malignancy in most instances. An early sign of lymph node involvement is peripheral perfusion (capsular flow), and in later stages mixed (hilar and peripheral) perfusion is seen. Note that both reactive and malignant lymph nodes (except thyroid cancer metastases) are hypoechogenic compared with neighboring muscles.
Deep
Infiltration of muscularis propria and deeper.
Superficial
Infiltration to serosa only. be unsuitable for cytoreduction, n = 15). In cases in which the patient underwent only exploratory laparotomy (i.e. with early termination of laparotomy without attempt at cytoreduction), this was due to the discovery during surgery of inoperable findings, such as unexpected extensive upper abdominal disease or the combination of a large volume of ascites, signs of diffuse visceral carcinomatosis and retraction of the mesenteric root.
Rectosigmoid
The study criteria were met by 394 patients; their characteristics are described in Table 1 . The majority (293 patients (74%)) suffered from an advanced-stage tumor. Primary surgery was performed in 61% (n = 242) of patients and interval debulking surgery after neoadjuvant chemotherapy in 39% (n = 152). A complete resection of all macroscopic disease at primary or interval debulking surgery was achieved in 78% (n = 306) of patients. Table 2 gives an overview of the predictive power of ultrasound in determining tumor burden and a detailed analysis is presented in Table S2 . The best predictive power, with AUC > 0.8 and high values for both sensitivity (> 80%) and specificity (> 90%), was obtained for detection of pelvic carcinomatosis and depth of rectosigmoid wall infiltration. In particular, preoperative ultrasound assessment of rectosigmoid wall infiltration depth had the highest kappa agreement with pathological staging (kappa, 0.812) ( Table 3) . Ultrasound assessment of peritoneal carcinomatosis in the upper and middle abdomen gave AUCs mostly between 0.6 and 0.7, but sensitivity was < 50%; the only exception was in the assessment of omental infiltration, with AUC = 0.804 and sensitivity 67.3%, although the specificity remained > 90% (Table 2) .
Test results and estimates
With the exception of miliary carcinomatosis on viscera (liver, spleen) and mesentery, the size of miliary and nodular carcinomatosis at ultrasound was highly statistically significantly similar to that on intraoperative findings (Table S2) .
Ultrasound showed excellent specificity (99%) for the detection of metastatic retroperitoneal and inguinal lymph nodes; however, sensitivity was low for the retroperitoneum (34.5%). The high sensitivity in detection of metastatic inguinal lymph nodes (100%) was related to the fact that we operated on only patients with positive ultrasound findings in the groin (Table 2 ).
In the detection of free fluid in the peritoneal and pleural cavity, ultrasound showed very good results (Table S2) .
In assigning patients to the correct FIGO stage (Stage I-IV), according to disease spread, ultrasound achieved the highest sensitivity (90.7%) for Stage I and the highest specificity (99.7%) for Stage IV (Table S2) . Results are shown for available data only (not all characteristics were available for complete sample dataset); only examined parameters with more than one finding are shown. *Based on receiver-operating characteristics (ROC) curve analysis. †Only inguinal lymph nodes evaluated on ultrasound as infiltrated were removed (n = 9). AUC, area under the ROC curve; FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; TN, true negative; TP, true positive.
DISCUSSION
This is the largest study to date showing the high accuracy of preoperative ultrasound for evaluation of pelvic carcinomatosis (AUC, 0.892; sensitivity, 81.4%; specificity, 97.0%), and for rectosigmoid wall infiltration in particular (AUC, 0.898; sensitivity, 83.1%; specificity, 96.6%), with histology as a reference standard. In contrast, for the evaluation of peritoneal involvement in the upper and middle abdomen, as well as for retroperitoneal lymph node assessment, the sensitivity of ultrasound was poor, although specificity remained high (> 90%). Furthermore, based on its high specificity, ultrasound can be used safely to plan dissection of metastatic inguinal lymph nodes.
The strength of this study lies in its prospective design, the inclusion of a large number of patients with advanced ovarian cancer (n = 293 (74%)), the use of standardized ultrasound methodology and terminology for ovarian cancer staging, and the use of a predefined ultrasound and intraoperative study evaluation form complemented with pathological staging. Furthermore, on sonography we classified implants according to size (≤ 3 mm, miliary; > 3 mm, nodular) to reflect typical intraoperative findings. Other imaging studies have been aimed at evaluation of much larger implants; a Radiological Diagnostic Oncology Group (RDOG) 20 study on ultrasound, MRI and CT classified implants according to size ≤ 2 cm and > 2 cm, while the study by Michielsen et al. 17 classified peritoneal nodules as ≤ 1 cm and > 1 cm. The role of ultrasound in ovarian cancer staging, however, could not be addressed fully for the whole population of patients with ovarian cancer, since only those who underwent surgery with complete pathological staging were included. These patients represent a select group who were without obvious signs of inoperability. Furthermore, interobserver analysis was not part of the study protocol; nor was comparison between ultrasound and any other modern imaging method. As CT alone or PET/CT were performed in only a minority of patients, our study unfortunately did not permit comparison of the accuracy of ultrasound with that of other imaging modalities.
The potential role of transvaginal sonography to detect peritoneal carcinomatosis in the pelvis was shown by Savelli et al., who described its nodular and sheet-like appearance in 53 patients 28 . Testa et al. 21 , using transvaginal ultrasound in 147 patients with advanced ovarian cancer, obtained similar results to ours for the detection of massive peritoneal involvement in the pelvis (sensitivity, 94% vs our 89%; specificity, 97% vs our 99%). In our study, we found that a high-resolution transvaginal probe enabled detailed assessment of miliary (≤ 3 mm) peritoneal carcinomatosis, with the best predictive power being in the pouch of Douglas (AUC > 0.8) ( Figure 5 and Videoclip S1). Furthermore, ultrasound allowed a detailed assessment of tumor infiltration depth in the rectosigmoid wall, with the highest overall accuracy and sensitivity (91.1% and 83.1%) when compared with other evaluated parameters. Moreover, our results are also comparable with those of a recently published study by Michielsen et al. 17 comparing whole-body MRI with DWI (WB-DWI/MRI) for ovarian cancer staging with CT and 18 F-fluorodeoxyglucose (FDG)-PET/CT; in the assessment of pelvic carcinomatosis, WB-DWI/MRI had a sensitivity of 92% (vs our 81%) and specificity of 95% (vs our 97%), while CT and PET/CT achieved a significantly lower sensitivity (sensitivity, 56% and 36%; specificity, 95% and 100%, respectively).
In contrast, using transabdominal ultrasound, it was almost impossible to detect miliary spread in the abdomen, although this is often observed intraoperatively; this was reflected in the low sensitivity of ultrasound. However, in terms of accuracy, our results were comparable to those of other modern imaging methods 17 , and the AUC for the evaluation of any peritoneal carcinomatosis was 0.871 ( Figures 6 and 7 and Videoclips S2 and S3). Ultrasound assessment for identification of upper and middle abdomen infiltration showed high specificity (> 90%), but sensitivity was generally < 50%; the exception was for assessment of omental infiltration, with an AUC of 0.804 and sensitivity of 67.3%. Michielsen et al. 17 obtained a sensitivity for any peritoneal assessment by WB-DWI/MRI, CT and PET/CT of 91%, 65% and 52%, respectively. For peritoneal staging, WB-DWI/MRI had higher accuracy (91%) than did CT (75%) and FDG-PET/CT (71%), while, in our study, when using ultrasound for evaluation of peritoneal staging, the overall sensitivity and accuracy were 82.5% and 85.3%, respectively.
Our results, showing that ultrasound is a highly specific technique in the assessment of peritoneal involvement (specificity, 91.7%), confirm those of an RDOG study 20 which used ultrasound in ovarian cancer staging in 118 patients and reported a specificity of 93%. Furthermore, we obtained higher sensitivity than did the RDOG study (82.5% vs 69%). This discrepancy might be due to the technical improvements to ultrasound in the past 15 years, since the RDOG study.
For the detection at ultrasound of retroperitoneal lymphadenopathy, we found an accuracy of 84.8% (Figure 8 and Videoclip S4), and our data confirm the RDOG study's findings 20 of high specificity (99.0% and 93%, respectively) but lower sensitivity (34.5% and 32%, respectively). In the Michielsen study 17 , WB-DWI/MRI and FDG-PET/CT showed a similar accuracy of 87% for detecting retroperitoneal lymphadenopathy, with a lower accuracy of 71% for CT. The sensitivity was shown to be >50% for all three modalities. The highest sensitivity, 77%, was found for WB-DWI/MRI and FDG-PET/CT, with a lower sensitivity (54%) for CT. The relatively low sensitivity of all imaging techniques in retroperitoneal staging further supports the role of comprehensive surgical staging.
From a clinical point of view, ultrasound examination can be carried out directly by gynecological oncologists, with all the benefits that their knowledge of the disease brings. In our study, ultrasound showed very good results in the assessment of visible peritoneal involvement (≥ 3 mm) in ovarian cancer and, based on its high specificity, it is a good method of choice for the initial selection of patients for primary debulking or neoadjuvant chemotherapy if an experienced examiner and high-end equipment are available. Other modern methods, such as CT, PET/CT or WB-DWI/MRI, can be reserved for patients not easily accessible by ultrasound or patients in whom supradiaphragmatic spread is expected 10 . In addition to high specificity, ultrasound had high sensitivity in the assessment of depth of infiltration in the rectosigmoid wall and inguinal lymph nodes; it can therefore be used safely to plan rectosigmoid resection and inguinofemoral dissection. The main limitation of all imaging methods is that miliary mesenteric and intestinal involvement can go undetected preoperatively, which may contribute to suboptimal surgical results. The addition of diagnostic laparoscopy prior to open surgery would perhaps prevent this.
Future studies should focus on evaluation of multicenter interobserver agreement and comparison of other modern imaging methods with ultrasound in the assessment of advanced tumor staging using standardized terminology and methodology. In conclusion, ultrasound is already accepted as a method of choice in characterizing primary ovarian tumors. This is the largest prospective study to demonstrate additionally its excellent predictive power in the evaluation of pelvic peritoneal carcinomatosis, including assessment of depth of tumor infiltration in the rectosigmoid wall and detection of metastatic inguinal lymph nodes. In assessing abdominal peritoneal and retroperitoneal compartments, we found ultrasound to be accurate and highly specific, but with relatively low sensitivity.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: Table S1 Study evaluation form for preoperative ultrasound and intraoperative/pathological evaluation of women undergoing primary cytoreductive surgery for suspected ovarian cancer 
